SR

Samruddha Rahul Wavikar

Active Director Director DIN 10807531
DIN 10807531 First appointment Oct 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Samruddha Rahul Wavikar

Data last updated:

Samruddha Rahul Wavikar is a Director at Metayu Pharmatech Private Limited (since 2024). The company operates in Paper.

DIN 10807531
Primary Designation Director
Industry Paper
First Appointment 14 Oct 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Metayu Pharmatech Private Limited U21009MH2024PTC433525
Director14 Oct 20242024Active

Board colleagues of Samruddha Rahul Wavikar

Directorship timeline

Open interactive timeline →
Metayu Pharmatech Private Limited
Premium access

Shareholding and investment profile for Samruddha Rahul Wavikar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Samruddha Rahul Wavikar

Samruddha Rahul Wavikar currently holds 1 directorship: Metayu Pharmatech Private Limited (Director, since 14 Oct 2024).

Samruddha Rahul Wavikar was first appointed on 14 Oct 2024 as Director at Metayu Pharmatech Private Limited.

The current boards of Samruddha Rahul Wavikar's companies include Gayatri Rahul Wavikar (Metayu Pharmatech Private Limited), Kaustubh Sandeep Joshi (Metayu Pharmatech Private Limited), Sneha Sandeep Joshi (Metayu Pharmatech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available